Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 169 institutions that hold shares in the stock, with a total of 109 Million shares, which have been reported (via 13F filing form) to have a value of $403 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Trustcore Financial Services, LLC
|
Feb 13, 2023 Q4 2022 |
161
shares
|
$594
0.0% of portfolio
|
Q4 2021
Reduced 66.53%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
75
shares
|
$276
0.0% of portfolio
|
Q2 2021
Added 400.0%
|
|
|
Cornerstone Planning Group LLC
Fairfield, NJ |
Nov 04, 2025 Q3 2025 |
34
shares
|
$125
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Dcvc Bio Gp, LLC
Palo Alto, CA |
Nov 14, 2022 Q3 2022 |
0
shares
|
$0
100.0% of portfolio
|
Q3 2022
Closed
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|